Laffer Tengler Investments Vertex Pharmaceuticals Inc Transaction History
Laffer Tengler Investments
- $494 Billion
- Q3 2024
A detailed history of Laffer Tengler Investments transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Laffer Tengler Investments holds 2,874 shares of VRTX stock, worth $1.42 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
2,874
Previous 2,792
2.94%
Holding current value
$1.42 Million
Previous $1.31 Billion
2.14%
% of portfolio
0.27%
Previous 0.28%
Shares
6 transactions
Others Institutions Holding VRTX
# of Institutions
1,728Shares Held
225MCall Options Held
1.21MPut Options Held
1.44M-
Capital World Investors Los Angeles, CA26.8MShares$13.3 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$11.5 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.5 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.84 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.45 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $127B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...